Loading the lesson
Loading the lesson
Search AllRounder.ai
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today's lesson is focused on gene therapy, which we define as the introduction of genetic material into a patient to treat or prevent disease. Can anyone tell me why gene therapy is such an important aspect of modern medicine?
It helps fix genetic disorders or replace missing genes that cause diseases!
Exactly! Now, we have two main types of gene therapy: somatic and germline. Somatic gene therapy only affects the treated individual, while germline therapy can alter genes in egg or sperm cells. Let's remember this with the acronym SAGE: Somatic and Germline Effects.
What's the difference in acceptance between the two?
Good question! Somatic therapy is widely accepted, while germline therapy is often controversial due to ethical concerns. Can anyone think of an example of somatic gene therapy?
Isn't Luxturna for Leber’s Congenital Amaurosis a case of somatic therapy?
Right! Well done. Let's summarize: Gene therapy can target a specific genetic defect in somatic cells without affecting future generations. Remember SAGE as a mnemonic for somatic and germline therapies.
In this session, we’ll cover gene delivery systems. Does anyone know the methods we use to deliver genes into cells?
Viral vectors and non-viral methods!
Correct! Viral vectors, like AAV and lentiviruses, allow for long-term gene expression, while non-viral methods, like liposomes and electroporation, generally provoke a lower immune response. Let’s use the mnemonic VINE to remember: Viral and Invasive Non-viral Expressing systems.
How do we choose which method to use in therapy?
Great question! The choice depends on disease type, required duration of expression, and safety. For instance, CAR-T therapy utilizes modified T-cells that are reinfused into the patient. Let's summarize: The delivery method is crucial in its effectiveness, and VINE helps us remember the two categories.
Let's discuss clinical applications. Can anyone cite a disease treated using gene therapy?
Yes, Luxturna treats Leber’s Congenital Amaurosis by restoring vision.
Exactly! Luxturna is an excellent example of successful gene therapy. Also, Zolgensma for Spinal Muscular Atrophy delivers the SMN1 gene. Remember LZ: Luxturna for vision and Zolgensma for muscles.
What about therapies for cancer?
For cancer, we use CAR-T therapy, which engineered T-cells to target cancer cells. So, summarizing, gene therapy has real-world applications, and remember LZ to recall vision and muscle therapies.
We must also address the ethical aspects of gene therapy. Why do you think informed consent is crucial?
Patients need to understand the risks and benefits of the treatment.
Great point! Informed consent ensures patients are aware of what they are undergoing. Additionally, germline editing is banned in various countries due to ethical concerns. Let’s remember IRE: Informed consent, Regulation, Ethics.
What about the regulatory bodies involved?
Regulatory bodies like the FDA in the USA, EMA in Europe, and ICMR in India. They oversee the safety of gene therapies. So, remember IRE for the essentials of ethical considerations in gene therapy.
Let’s discuss emerging trends in gene therapy. Can anyone name a new technology being researched?
CRISPR! It's being used in clinical trials.
Absolutely! CRISPR is revolutionary for gene editing and is being trialed for conditions like Sickle Cell Disease and Beta-Thalassemia. Let's remember CGE: CRISPR, Gene Editing.
What about personalized therapies?
Personalized gene therapies based on genome sequencing are paving the way for tailored treatments. Summarizing: Emerging trends like CGE highlight the future possibilities in gene therapy.
A method to treat diseases by correcting or replacing defective genes.
Alters the genes in somatic cells, affecting only the individual treated.
Alters reproductive cells, resulting in heritable changes.
Methods for introducing genetic material into cells, including viral and non-viral systems.
Real-world use cases of gene therapy in treating various diseases.
Important legal and moral issues surrounding gene therapy and genetic modifications.
Gene therapy's a healing quest, fixing genes to help you best.
Imagine a factory, the body, making proteins. If a machine breaks (the gene), employees (the cells) stumble. Gene therapy fixes that machine to enhance overall production.
Use GAG for Gene therapy's aims: Gene correction, Active repair, Genetic enhancement.
Remember LZ for Luxturna and Zolgensma to recall key gene therapies.
Term
Gene Therapy
Click to flip
Term
Somatic Gene Therapy
Click to flip
Term
Germline Gene Therapy
Click to flip
Term
Viral Vectors
Click to flip
Term
Clinical Applications
Click to flip
The introduction of genetic material into a patient to treat or prevent disease.
Gene therapy that affects only the treated individual.
Gene therapy that alters genes in eggs or sperm, which is heritable.
Modified viruses used in gene therapy for long-term gene expression.
Gene delivery techniques that include liposomes and electroporation, leading to lower immune responses.
A type of immunotherapy that modifies T-cells to attack cancer.
A process whereby patients are informed of the risks and benefits before participating in treatment.
A gene-editing technology used to modify DNA sequences and gene function.
This chapter summarizes the principles, challenges, and future directions of gene therapy in treating human diseases.
The chapter provides an overview of the key concepts in gene therapy, including somatic and germline strategies, the effectiveness of various delivery systems, and ethical considerations. It highlights current successful therapies and outlines future trends in personalized medicine.
This chapter encapsulates the essential aspects of gene therapy, which aims to correct or replace defective genes in patients to treat genetic and acquired diseases.
It emphasizes the importance of gene delivery systems, both viral and non-viral, which are crucial for the effective application of therapies like Luxturna and Zolgensma.
Moreover, the chapter discusses regulatory and safety considerations central to the acceptance of gene therapies in clinical settings. With emerging trends in CRISPR technology and personalized medicine fueled by genomics and AI, the future of gene therapy is promising yet complex. The integration of ethical considerations remains paramount as society navigates the possibilities and perils of genetic modification.